Artificial heart offers hope for transplant candidates
Disease control
Ongoing
This study is testing the Carmat Total Artificial Heart in 104 people with severe, irreversible heart failure who are waiting for a heart transplant. The device is designed to replace both heart chambers and keep patients alive until a donor heart becomes available. Researchers a…
Phase: NA • Sponsor: Carmat SAS • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC